Figure 6
From: Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
Images of the change in hair loss following 24 consecutive weeks of application of SAMiRNA-AR68 at 5 mg/ml and placebo products. (a) Representative photographs of the forehead hairline and vertex of the two groups at baseline and 8, 16 and 24 weeks after 5 mg/ml AR68 and placebo treatment once a week. The phototrichogram analysis was performed at baseline and at 16 and 24 weeks. (b) Representative graph of the percentage of total hair count increments at 16 and 24 weeks compared to baseline.
